Molecular basis for prospective pharmacological treatment strategies in intellectual disability syndromes.
about
Lipid binding defects and perturbed synaptogenic activity of a Collybistin R290H mutant that causes epilepsy and intellectual disability.Genetic studies in intellectual disability and related disorders.Genetic Approaches to Understanding Psychiatric Disease.Emerging roles of Na⁺/H⁺ exchangers in epilepsy and developmental brain disorders.Epigenomic mapping and effect sizes of noncoding variants associated with psychotropic drug response.Rescue of learning and memory deficits in the human non-syndromic intellectual disability cereblon knockout mouse model by targeting the AMPK-mTORC1 translational pathway.
P2860
Molecular basis for prospective pharmacological treatment strategies in intellectual disability syndromes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular basis for prospectiv ...... llectual disability syndromes.
@en
type
label
Molecular basis for prospectiv ...... llectual disability syndromes.
@en
prefLabel
Molecular basis for prospectiv ...... llectual disability syndromes.
@en
P2860
P356
P1476
Molecular basis for prospectiv ...... llectual disability syndromes.
@en
P2093
Baltazar Gomez-Mancilla
Ivan Galimberti
P2860
P304
P356
10.1002/DNEU.22093
P577
2013-07-19T00:00:00Z